Inositol efficacy on OHSS risk may be due to a beneficial effect on the abnormal ovarian/follicle dynamics [88,89] but also the expression of cyclooxygenase type 2 (COX-2) and VEGF with suppression of vascular permeability [90]. Here, VEGFA is linked to ovarian hyperstimulation syndrome.